The Impact of b/tsDMARD Dose Reduction on Chronic Hepatitis B in Rheumatoid Arthritis Patients: A Two-Center Long-Term Safety Analysis.

Der-Yuan Chen Hsin-Hua ChenShih-Hsin ChangYi Ming ChenPo-Hao HuangChia-Wei HsiehJoung-Liang LanKuo-Tung Tang

Published in: Journal of clinical medicine (2022)

The HBV viral load decreased after the tapering of b/tsDMARDs in RA patients with detectable HBV DNA. Dose reduction in b/tsDMARDs might be beneficial.

Keyphrases

hepatitis b virus
rheumatoid arthritis patients
disease activity
liver failure
rheumatoid arthritis
systemic lupus erythematosus
circulating tumor
cell free
ankylosing spondylitis
interstitial lung disease
nucleic acid
systemic sclerosis